Call for projects concerning innovative implants and surgical robots launched under the France 2030 Plan

On January 1, 2026, the Order of the French Prime Minister approved the specifications of the call for projects "Support for disruptive innovations in the implantable medical devices and surgical robotics sector" as part of the France 2030 investment plan. The call focuses on two strategic axes:

• Implantable medical devices: Projects must demonstrate disruptive advances in materials or biomaterials, functions, or performance and safety;
• Next-generation surgical robots: Projects should enhance the surgeon-patient interface, advance mechatronics components, introduce innovations in robotic procedure planning, enhance modularity and versatility of procedures, and improve the learning curve, while contributing to more economically accessible solutions for healthcare providers.

The call for projects targets developments built on prior work at a technological maturity TRL of 4–6 and moving to a TRL of 7–9. The project implementation may include industrial research phases as well as experimental development phases, prior to market entry. Projects must have a total budget exceeding €4 million, a maximum duration of 48 months, and relate to work carried out in France that has not been initiated prior to application submission.

For research organizations, aid will be provided in the form of grants. For companies, aid is split 50/50 between non-repayable subsidies and repayable advances. Large companies cannot apply on their own and may participate only within a consortium (of up to 6 partners).

Beyond technical innovation, applicants must demonstrate compliance with the "Do No Significant Harm" environmental principle and present the target market beyond French institutional clients.

The application process is managed via the Bpifrance online platform, with submissions accepted until October 6, 2026 (with intermediate processing on February 10, 2026).

See full details in French here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.